ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
profitability factor · long-only model fund

Foundry Return on Assets Industry-Neutral Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FRORHYPOTHETICAL MODEL
Since ’99
+179%
Expense Ratio
0.35%
placeholder
Holdings
298
cap-weighted
Inception
Sep 2021
placeholder
Full Sharpe
0.31
Ann. Return (LS)
5.1%
Ann. Volatility
16.3%
Max Drawdown
-45.8%
Test Sharpe ’19–26
0.35
Test FF5 α (ann.)
8.8%
vs Fama-French 5
Test FF5 α t-stat
1.85
not significant
Monthly turnover
13%
of the long leg, per rebalance
Cumulative return (LS)
179%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.63
what this fund holds
Long leg ann. return
10.0%
buyable, long-only
Long-short Sharpe
0.31
requires shorting
Bottom bucket ann. return
5.0%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

298 of 298 · 100.0% of book
TickerCompanySectorMarket capWeight
1NVDA
NVIDIA CORPTechnology$4.91T
26.29%
2AAPL
APPLE INCTechnology$4.90T
26.26%
3LLY
ELI LILLY & COHealthcare$1.11T
5.95%
4MU
MICRON TECHNOLOGY INCTechnology$958.80B
5.14%
5JNJ
JOHNSON & JOHNSONHealthcare$609.12B
3.26%
6ABBV
ABBVIE INCHealthcare$449.63B
2.41%
7GE
GE AEROSPACEIndustrials$361.93B
1.94%
8KO
COCA COLA COConsumer Defensive$350.91B
1.88%
9MRK
MERCK & CO INCHealthcare$314.90B
1.69%
10GEV
GE VERNOVA INCUtilities$284.26B
1.52%
11AMGN
AMGEN INCHealthcare$197.69B
1.06%
12MCD
MCDONALDS CORPConsumer Cyclical$190.21B
1.02%
13PEP
PEPSICO INCConsumer Defensive$187.15B
1.00%
14ABT
ABBOTT LABORATORIESHealthcare$175.37B
0.94%
15GILD
GILEAD SCIENCES INCHealthcare$166.72B
0.89%
16WDC
WESTERN DIGITAL CORPTechnology$164.49B
0.88%
17PFE
PFIZER INCHealthcare$142.77B
0.76%
18APP
APPLOVIN CORPTechnology$142.62B
0.76%
19BMY
BRISTOL MYERS SQUIBB COHealthcare$124.04B
0.66%
20VRTX
VERTEX PHARMACEUTICALS INCHealthcare$123.26B
0.66%
21SYK
STRYKER CORPHealthcare$122.63B
0.66%
22ISRG
INTUITIVE SURGICAL INCHealthcare$122.33B
0.66%
23SBUX
STARBUCKS CORPConsumer Cyclical$120.23B
0.64%
24MDT
MEDTRONIC PLCHealthcare$106.50B
0.57%
25MAR
MARRIOTT INTERNATIONAL INCConsumer Cyclical$96.57B
0.52%
26MMM
3M COIndustrials$83.37B
0.45%
27EMR
EMERSON ELECTRIC COIndustrials$78.14B
0.42%
28HLT
HILTON WORLDWIDE HOLDINGS INCConsumer Cyclical$73.15B
0.39%
29REGN
REGENERON PHARMACEUTICALS INCHealthcare$70.94B
0.38%
30BSX
BOSTON SCIENTIFIC CORPHealthcare$65.44B
0.35%
31BE
BLOOM ENERGY CORPIndustrials$61.14B
0.33%
32AME
AMETEK INCIndustrials$54.32B
0.29%
33EW
EDWARDS LIFESCIENCES CORPHealthcare$49.36B
0.26%
34IDXX
IDEXX LABORATORIES INCHealthcare$44.76B
0.24%
35CMG
CHIPOTLE MEXICAN GRILL INCConsumer Cyclical$44.18B
0.24%
36BDX
BECTON DICKINSON & COHealthcare$43.58B
0.23%
37KDP
KEURIG DR PEPPER INCConsumer Defensive$42.05B
0.23%
38YUM
YUM BRANDS INCConsumer Cyclical$40.77B
0.22%
39TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTDHealthcare$37.30B
0.20%
40ALNY
ALNYLAM PHARMACEUTICALS INCHealthcare$35.71B
0.19%
41ONC
BEONE MEDICINES LTDHealthcare$34.68B
0.19%
42RPRX
ROYALTY PHARMA PLCHealthcare$33.50B
0.18%
43UI
UBIQUITI INCTechnology$33.04B
0.18%
44ZTS
ZOETIS INCHealthcare$32.10B
0.17%
45BIIB
BIOGEN INCHealthcare$30.41B
0.16%
46LVS
LAS VEGAS SANDS CORPConsumer Cyclical$30.06B
0.16%
47DXCM
DEXCOM INCHealthcare$29.58B
0.16%
48FICO
FAIR ISAAC CORPTechnology$29.15B
0.16%
49RMD
RESMED INCHealthcare$28.86B
0.15%
50GEHC
GE HEALTHCARE TECHNOLOGIES INCHealthcare$28.69B
0.15%
51OTIS
OTIS WORLDWIDE CORPIndustrials$28.18B
0.15%
52QSR
RESTAURANT BRANDS INTERNATIONAL INCConsumer Cyclical$26.03B
0.14%
53VRSN
VERISIGN INCTechnology$25.27B
0.14%
54ROIV
ROIVANT SCIENCES LTDHealthcare$24.82B
0.13%
55WWD
WOODWARD INCIndustrials$23.41B
0.13%
56DRI
DARDEN RESTAURANTS INCConsumer Cyclical$22.74B
0.12%
57UTHR
UNITED THERAPEUTICS CORPHealthcare$22.74B
0.12%
58STZ
CONSTELLATION BRANDS INCConsumer Defensive$22.69B
0.12%
59STE
STERIS PLCHealthcare$21.26B
0.11%
60VTRS
VIATRIS INCHealthcare$20.14B
0.11%
61H
HYATT HOTELS CORPConsumer Cyclical$17.95B
0.10%
62ZBH
ZIMMER BIOMET HOLDINGS INCHealthcare$17.63B
0.09%
63NBIX
NEUROCRINE BIOSCIENCES INCHealthcare$17.18B
0.09%
64JAZZ
JAZZ PHARMACEUTICALS PLCHealthcare$15.53B
0.08%
65YUMC
YUM CHINA HOLDINGS INCConsumer Cyclical$15.32B
0.08%
66ARMK
ARAMARKIndustrials$14.92B
0.08%
67SOLV
SOLVENTUM CORPHealthcare$14.08B
0.08%
68COO
COOPER COMPANIES INCHealthcare$13.99B
0.07%
69RRX
REGAL REXNORD CORPIndustrials$13.77B
0.07%
70TXRH
TEXAS ROADHOUSE INCConsumer Cyclical$12.95B
0.07%
71ELAN
ELANCO ANIMAL HEALTH INCHealthcare$12.90B
0.07%
72ALGN
ALIGN TECHNOLOGY INCHealthcare$12.66B
0.07%
73GNRC
GENERAC HOLDINGS INCIndustrials$12.65B
0.07%
74PEN
PENUMBRA INCHealthcare$12.52B
0.07%
75BROS
DUTCH BROS INCConsumer Cyclical$11.94B
0.06%
76MGM
MGM RESORTS INTERNATIONALConsumer Cyclical$11.80B
0.06%
77BF.B
BROWN FORMAN CORPConsumer Defensive$11.74B
0.06%
78BAX
BAXTER INTERNATIONAL INCHealthcare$11.68B
0.06%
79BMRN
BIOMARIN PHARMACEUTICAL INCHealthcare$11.52B
0.06%
80PODD
INSULET CORPHealthcare$11.36B
0.06%
81TECH
BIO-TECHNE CORPHealthcare$11.29B
0.06%
82ARWR
ARROWHEAD PHARMACEUTICALS INCHealthcare$10.47B
0.06%
83KRYS
KRYSTAL BIOTECH INCHealthcare$10.46B
0.06%
84GMED
GLOBUS MEDICAL INCHealthcare$10.45B
0.06%
85APGE
APOGEE THERAPEUTICS INCHealthcare$10.10B
0.05%
86LFUS
LITTELFUSE INCTechnology$10.06B
0.05%
87WYNN
WYNN RESORTS LTDConsumer Cyclical$10.03B
0.05%
88AYI
ACUITY INC (DE)Industrials$9.99B
0.05%
89CORT
CORCEPT THERAPEUTICS INCHealthcare$9.72B
0.05%
90KYMR
KYMERA THERAPEUTICS INCHealthcare$9.52B
0.05%
91HALO
HALOZYME THERAPEUTICS INCHealthcare$9.23B
0.05%
92PTGX
PROTAGONIST THERAPEUTICS INCHealthcare$9.06B
0.05%
93IONS
IONIS PHARMACEUTICALS INCHealthcare$8.99B
0.05%
94ALKS
ALKERMES PLCHealthcare$8.79B
0.05%
95PRAX
PRAXIS PRECISION MEDICINES INCHealthcare$8.77B
0.05%
96SYRE
SPYRE THERAPEUTICS INCHealthcare$8.70B
0.05%
97POWL
POWELL INDUSTRIES INCIndustrials$8.48B
0.05%
98TGTX
TG THERAPEUTICS INCHealthcare$8.40B
0.04%
99RGEN
REPLIGEN CORPHealthcare$8.31B
0.04%
100EAT
BRINKER INTERNATIONAL INCConsumer Cyclical$8.12B
0.04%
101CAVA
CAVA GROUP INCConsumer Cyclical$8.02B
0.04%
102TAP
MOLSON COORS BEVERAGE COConsumer Defensive$7.28B
0.04%
103LQDA
LIQUIDIA CORPHealthcare$7.11B
0.04%
104LNTH
LANTHEUS HOLDINGS INCHealthcare$7.00B
0.04%
105RRR
RED ROCK RESORTS INCConsumer Cyclical$6.76B
0.04%
106MSA
MSA SAFETY INCIndustrials$6.60B
0.04%
107BYD
BOYD GAMING CORPConsumer Cyclical$6.52B
0.03%
108PTCT
PTC THERAPEUTICS INCHealthcare$6.52B
0.03%
109CGON
CG ONCOLOGY INCHealthcare$6.34B
0.03%
110CZR
CAESARS ENTERTAINMENT INCConsumer Cyclical$6.08B
0.03%
111LGND
LIGAND PHARMACEUTICALS INCHealthcare$6.08B
0.03%
112TFX
TELEFLEX INCHealthcare$5.96B
0.03%
113TWST
TWIST BIOSCIENCE CORPHealthcare$5.84B
0.03%
114BLCO
BAUSCH & LOMB CORPHealthcare$5.80B
0.03%
115DNTH
DIANTHUS THERAPEUTICS INCHealthcare$5.77B
0.03%
116WH
WYNDHAM HOTELS & RESORTS INCConsumer Cyclical$5.73B
0.03%
117AMRX
AMNEAL PHARMACEUTICALS INCHealthcare$5.69B
0.03%
118ORKA
ORUKA THERAPEUTICS INCHealthcare$5.59B
0.03%
119NOVT
NOVANTA INCTechnology$5.30B
0.03%
120TVTX
TRAVERE THERAPEUTICS INCHealthcare$5.27B
0.03%
121CHH
CHOICE HOTELS INTERNATIONAL INCConsumer Cyclical$5.09B
0.03%
122KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL PLCHealthcare$4.92B
0.03%
123MMED
MINIMED GROUP INCHealthcare$4.75B
0.03%
124FELE
FRANKLIN ELECTRIC CO INCIndustrials$4.67B
0.03%
125CRSP
CRISPR THERAPEUTICS AGHealthcare$4.61B
0.02%
126TNL
TRAVEL & LEISURE COIndustrials$4.57B
0.02%
127LIVN
LIVANOVA PLCHealthcare$4.43B
0.02%
128AZZ
AZZ INCIndustrials$4.42B
0.02%
129MMSI
MERIT MEDICAL SYSTEMS INCHealthcare$4.41B
0.02%
130ACAD
ACADIA PHARMACEUTICALS INCHealthcare$4.38B
0.02%
131NVST
ENVISTA HOLDINGS CORPHealthcare$4.35B
0.02%
132CAKE
CHEESECAKE FACTORY INCConsumer Cyclical$4.26B
0.02%
133COCO
VITA COCO COMPANY INCConsumer Defensive$4.18B
0.02%
134HGV
HILTON GRAND VACATIONS INCConsumer Cyclical$3.98B
0.02%
135ICUI
ICU MEDICAL INCHealthcare$3.94B
0.02%
136WING
WINGSTOP INCConsumer Cyclical$3.88B
0.02%
137CPRX
CATALYST PHARMACEUTICALS INCHealthcare$3.85B
0.02%
138ADPT
ADAPTIVE BIOTECHNOLOGIES CORPHealthcare$3.67B
0.02%
139IRTC
IRHYTHM HOLDINGS INCHealthcare$3.64B
0.02%
140ARQT
ARCUTIS BIOTHERAPEUTICS INCHealthcare$3.56B
0.02%
141OGN
ORGANON & COHealthcare$3.55B
0.02%
142HAE
HAEMONETICS CORPHealthcare$3.54B
0.02%
143GPCR
STRUCTURE THERAPEUTICS INCHealthcare$3.45B
0.02%
144WRBY
WARBY PARKER INCHealthcare$3.24B
0.02%
145ELVN
ENLIVEN THERAPEUTICS INCHealthcare$3.24B
0.02%
146ITGR
INTEGER HOLDINGS CORPHealthcare$3.24B
0.02%
147IDYA
IDEAYA BIOSCIENCES INCHealthcare$3.16B
0.02%
148PK
PARK HOTELS & RESORTS INCReal Estate$3.00B
0.02%
149MBX
MBX BIOSCIENCES INCHealthcare$2.99B
0.02%
150BEAM
BEAM THERAPEUTICS INCHealthcare$2.83B
0.02%
151XRAY
DENTSPLY SIRONA INCHealthcare$2.81B
0.02%
152SUPN
SUPERNUS PHARMACEUTICALS INCHealthcare$2.79B
0.01%
153PENN
PENN ENTERTAINMENT INCConsumer Cyclical$2.75B
0.01%
154VISN
VISTANCE NETWORKS INCTechnology$2.74B
0.01%
155ESTA
ESTABLISHMENT LABS HOLDINGS INCHealthcare$2.72B
0.01%
156FLNC
FLUENCE ENERGY INCUtilities$2.59B
0.01%
157TARS
TARSUS PHARMACEUTICALS INCHealthcare$2.58B
0.01%
158TMDX
TRANSMEDICS GROUP INCHealthcare$2.56B
0.01%
159SHAK
SHAKE SHACK INCConsumer Cyclical$2.48B
0.01%
160ATKR
ATKORE INCIndustrials$2.48B
0.01%
161VCEL
VERICEL CORPHealthcare$2.38B
0.01%
162PBH
PRESTIGE CONSUMER HEALTHCARE INCHealthcare$2.36B
0.01%
163LMAT
LEMAITRE VASCULAR INCHealthcare$2.32B
0.01%
164NKTR
NEKTAR THERAPEUTICSHealthcare$2.31B
0.01%
165NEOG
NEOGEN CORPHealthcare$2.24B
0.01%
166MLYS
MINERALYS THERAPEUTICS INCHealthcare$2.23B
0.01%
167SHO
SUNSTONE HOTEL INVESTORS INCReal Estate$2.19B
0.01%
168MCRI
MONARCH CASINO & RESORT INCConsumer Cyclical$2.18B
0.01%
169AXGN
AXOGEN INCHealthcare$2.12B
0.01%
170GLUE
MONTE ROSA THERAPEUTICS INCHealthcare$2.07B
0.01%
171SPB
SPECTRUM BRANDS HOLDINGS INCConsumer Defensive$2.06B
0.01%
172AUPH
AURINIA PHARMACEUTICALS INCHealthcare$2.05B
0.01%
173RAPP
RAPPORT THERAPEUTICS INCHealthcare$2.04B
0.01%
174NUVB
NUVATION BIO INCHealthcare$2.03B
0.01%
175ADMA
ADMA BIOLOGICS INCHealthcare$2.02B
0.01%
176ABCL
ABCELLERA BIOLOGICS INCHealthcare$1.97B
0.01%
177HRMY
HARMONY BIOSCIENCES HOLDINGS INCHealthcare$1.96B
0.01%
178XHR
XENIA HOTELS & RESORTS INCReal Estate$1.94B
0.01%
179UFPT
UFP TECHNOLOGIES INCHealthcare$1.87B
0.01%
180MRVI
MARAVAI LIFESCIENCES HOLDINGS INCHealthcare$1.87B
0.01%
181SAM
BOSTON BEER CO INCConsumer Defensive$1.86B
0.01%
182SRPT
SAREPTA THERAPEUTICS INCHealthcare$1.82B
0.01%
183ANIP
ANI PHARMACEUTICALS INCHealthcare$1.80B
0.01%
184IMCR
IMMUNOCORE HOLDINGS PLCHealthcare$1.78B
0.01%
185ATRC
ATRICURE INCHealthcare$1.77B
0.01%
186ZYME
ZYMEWORKS INCHealthcare$1.77B
0.01%
187HROW
HARROW INCHealthcare$1.74B
0.01%
188ANAB
ANAPTYSBIO INCHealthcare$1.69B
0.01%
189EYE
NATIONAL VISION HOLDINGS INCConsumer Cyclical$1.66B
0.01%
190INVA
INNOVIVA INCHealthcare$1.60B
0.01%
191AMSC
AMERICAN SUPERCONDUCTOR CORPIndustrials$1.58B
0.01%
192XERS
XERIS BIOPHARMA HOLDINGS INCHealthcare$1.52B
0.01%
193SEPN
SEPTERNA INCHealthcare$1.51B
0.01%
194IART
INTEGRA LIFESCIENCES HOLDINGS CORPHealthcare$1.50B
0.01%
195PRGO
PERRIGO CO PLCHealthcare$1.48B
0.01%
196WEN
WENDY'S COConsumer Cyclical$1.48B
0.01%
197INSP
INSPIRE MEDICAL SYSTEMS INCHealthcare$1.46B
0.01%
198BLFS
BIOLIFE SOLUTIONS INCHealthcare$1.42B
0.01%
199BJRI
BJS RESTAURANTS INCConsumer Cyclical$1.42B
0.01%
200WINA
WINMARK CORPConsumer Cyclical$1.39B
0.01%
201ENR
ENERGIZER HOLDINGS INCIndustrials$1.39B
0.01%
202PAHC
PHIBRO ANIMAL HEALTH CORPHealthcare$1.35B
0.01%
203NVAX
NOVAVAX INCHealthcare$1.35B
0.01%
204PBT
PERMIAN BASIN ROYALTY TRUSTEnergy$1.32B
0.01%
205STAA
STAAR SURGICAL COHealthcare$1.32B
0.01%
206ATEC
ALPHATEC HOLDINGS INCHealthcare$1.31B
0.01%
207CNMD
CONMED CORPHealthcare$1.30B
0.01%
208XNCR
XENCOR INCHealthcare$1.30B
0.01%
209ARDX
ARDELYX INCHealthcare$1.28B
0.01%
210CRVS
CORVUS PHARMACEUTICALS INCHealthcare$1.25B
0.01%
211CDRE
CADRE HOLDINGS INCIndustrials$1.24B
0.01%
212IRMD
IRADIMED CORPHealthcare$1.24B
0.01%
213AORT
ARTIVION INCHealthcare$1.22B
0.01%
214CBRL
CRACKER BARREL OLD COUNTRY STORE INCConsumer Cyclical$1.20B
0.01%
215QDEL
QUIDELORTHO CORPHealthcare$1.19B
0.01%
216TNDM
TANDEM DIABETES CARE INCHealthcare$1.17B
0.01%
217COLL
COLLEGIUM PHARMACEUTICAL INCHealthcare$1.17B
0.01%
218AVNS
AVANOS MEDICAL INCHealthcare$1.17B
0.01%
219ETON
ETON PHARMACEUTICALS INCHealthcare$1.16B
0.01%
220SDGR
SCHRODINGER INCHealthcare$1.14B
0.01%
221PZZA
PAPA JOHNS INTERNATIONAL INCConsumer Cyclical$1.08B
0.01%
222BIOA
BIOAGE LABS INCHealthcare$1.01B
0.01%
223PCRX
PACIRA BIOSCIENCES INCHealthcare$1.01B
0.01%
224BVS
BIOVENTUS INCHealthcare$1.01B
0.01%
225JANX
JANUX THERAPEUTICS INCHealthcare$992M
0.01%
226BH
BIGLARI HOLDINGS INCConsumer Cyclical$882M
0.00%
227LYTS
LSI INDUSTRIES INCTechnology$879M
0.00%
228TBPH
THERAVANCE BIOPHARMA INCHealthcare$873M
0.00%
229AMPH
AMPHASTAR PHARMACEUTICALS INCHealthcare$871M
0.00%
230SG
SWEETGREEN INCConsumer Cyclical$841M
0.00%
231CYRX
CRYOPORT INCIndustrials$832M
0.00%
232SIBN
SI-BONE INCHealthcare$771M
0.00%
233FWRG
FIRST WATCH RESTAURANT GROUP INCConsumer Cyclical$768M
0.00%
234ZVRA
ZEVRA THERAPEUTICS INCHealthcare$755M
0.00%
235RIGL
RIGEL PHARMACEUTICALS INCHealthcare$750M
0.00%
236WEST
WESTROCK COFFEE COConsumer Defensive$749M
0.00%
237MNPR
MONOPAR THERAPEUTICSHealthcare$744M
0.00%
238BLMN
BLOOMIN' BRANDS INCConsumer Cyclical$731M
0.00%
239OMER
OMEROS CORPHealthcare$701M
0.00%
240BALY
BALLY'S CORPConsumer Cyclical$688M
0.00%
241CRMD
CORMEDIX INCHealthcare$661M
0.00%
242TCMD
TACTILE SYSTEMS TECHNOLOGY INCHealthcare$648M
0.00%
243GYRE
GYRE THERAPEUTICS INCHealthcare$587M
0.00%
244KRUS
KURA SUSHI USA INCConsumer Cyclical$567M
0.00%
245ANGO
ANGIODYNAMICS INCHealthcare$558M
0.00%
246CTNM
CONTINEUM THERAPEUTICS INCHealthcare$532M
0.00%
247LOCO
EL POLLO LOCO HOLDINGS INCConsumer Cyclical$505M
0.00%
248XOMA
XOMA ROYALTY CORPHealthcare$504M
0.00%
249KIDS
ORTHOPEDIATRICS CORPHealthcare$494M
0.00%
250OFIX
ORTHOFIX MEDICAL INCHealthcare$468M
0.00%
251DIN
DINE BRANDS GLOBAL INCConsumer Cyclical$456M
0.00%
252DCTH
DELCATH SYSTEMS INCHealthcare$442M
0.00%
253PBYI
PUMA BIOTECHNOLOGY INCHealthcare$434M
0.00%
254ASMB
ASSEMBLY BIOSCIENCES INCHealthcare$426M
0.00%
255USNA
USANA HEALTH SCIENCES INCConsumer Defensive$403M
0.00%
256ENTA
ENANTA PHARMACEUTICALS INCHealthcare$400M
0.00%
257ABEO
ABEONA THERAPEUTICS INCHealthcare$399M
0.00%
258EBS
EMERGENT BIOSOLUTIONS INCHealthcare$394M
0.00%
259NATH
NATHANS FAMOUS INCConsumer Cyclical$393M
0.00%
260CVEO
CIVEO CORPIndustrials$382M
0.00%
261EOLS
EVOLUS INCHealthcare$377M
0.00%
262FENC
FENNEC PHARMACEUTICALS INCHealthcare$365M
0.00%
263NATR
NATURES SUNSHINE PRODUCTS INCConsumer Defensive$359M
0.00%
264PLAY
DAVE & BUSTER'S ENTERTAINMENT INCCommunication Services$355M
0.00%
265ELMD
ELECTROMED INCHealthcare$349M
0.00%
266MSB
MESABI TRUSTBasic Materials$320M
0.00%
267TKNO
ALPHA TEKNOVA INCHealthcare$291M
0.00%
268JACK
JACK IN THE BOX INCConsumer Cyclical$286M
0.00%
269TTRX
TURN THERAPEUTICS INCHealthcare$272M
0.00%
270QTTB
Q32 BIO INCHealthcare$255M
0.00%
271RXST
RXSIGHT INCHealthcare$230M
0.00%
272UTMD
UTAH MEDICAL PRODUCTS INCHealthcare$222M
0.00%
273AGEN
AGENUS INCHealthcare$209M
0.00%
274ANIK
ANIKA THERAPEUTICS INCHealthcare$203M
0.00%
275RICK
RCI HOSPITALITY HOLDINGS INCConsumer Cyclical$200M
0.00%
276DERM
JOURNEY MEDICAL CORPHealthcare$197M
0.00%
277PDEX
PRO DEX INCHealthcare$183M
0.00%
278INFU
INFUSYSTEM HOLDINGS INCHealthcare$180M
0.00%
279INGN
INOGEN INCHealthcare$178M
0.00%
280RRGB
RED ROBIN GOURMET BURGERS INCConsumer Cyclical$130M
0.00%
281VTVT
VTV THERAPEUTICS INCHealthcare$130M
0.00%
282LAKE
LAKELAND INDUSTRIES INCConsumer Cyclical$113M
0.00%
283FTLF
FITLIFE BRANDS INCConsumer Defensive$104M
0.00%
284CPIX
CUMBERLAND PHARMACEUTICALS INCHealthcare$103M
0.00%
285ICCC
IMMUCELL CORPHealthcare$101M
0.00%
286ULBI
ULTRALIFE CORPIndustrials$92M
0.00%
287RLYB
RALLYBIO CORPHealthcare$87M
0.00%
288SOTK
SONO TEK CORPTechnology$86M
0.00%
289CSBR
CHAMPIONS ONCOLOGY INCHealthcare$85M
0.00%
290LFVN
LIFEVANTAGE CORPConsumer Defensive$78M
0.00%
291BDL
FLANIGANS ENTERPRISES INCConsumer Cyclical$76M
0.00%
292LNSR
LENSAR INCHealthcare$70M
0.00%
293STEM
STEM INCTechnology$56M
0.00%
294SNWV
SANUWAVE HEALTH INCHealthcare$55M
0.00%
295XLO
XILIO THERAPEUTICS INCHealthcare$53M
0.00%
296APT
ALPHA PRO TECH LTDBasic Materials$53M
0.00%
297BKHA
BLACK HAWK ACQUISITION CORPIndustrials$50M
0.00%
298TIL
INSTIL BIO INCHealthcare$50M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $18.67T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

10 sectors
Technology
59.9%
Healthcare
26.7%
Consumer Cyclical
4.3%
Industrials
4.2%
Consumer Defensive
3.4%
Utilities
1.5%
Real Estate
0.0%
Energy
0.0%
Basic Materials
0.0%
Communication Services
0.0%

Portfolio Style

Size × value map of the long-leg book

298 classified
Value
Blend
Growth
Large
Mid
Small
1%4
21%45
76%61
<1%20
<1%37
1%43
<1%22
<1%26
<1%14

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 99% toward Large, 88% toward Growth. +1% unclassified (26 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt99% → Large
SmallLarge
Value ↔ growth tilt88% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 298 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
1
Failed
4
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.

    Required
    >= 75.0%
    Actual
    56.4%
    Margin
    -18.6%
  • No more than 25% of total assets may be invested in the securities of any one issuer.

    Required
    <= 25.0%
    Actual
    26.3%
    Margin
    -1.3%
  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    31.6%
    Margin
    -6.6%
  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 298 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.0 (95% CI 0.7-1.2)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
9.7%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.01x
within
parametric
1.01x
within
cornish fisher
0.91x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

Publication date unknown. We don’t have a source year for this signal, so we can’t split its record into before and since publication. That’s a gap in our reference data — not a statement about how the factor performed.

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
77%
20 of 26 3-year windows made money
Worst window
-0.50
Sharpe, January 2004 – December 2006
January 1999July 2026
Median Sharpe
0.21
Dispersion
0.47
Best window
1.48

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.18.3%15.6%
3 yearsp.a.25.6%9.4%
5 yearsp.a.14.2%11.9%
10 yearsp.a.11.6%4.4%
Since inceptionp.a.9.1%3.8%
Calendar years
YearLong legLong-short
20267 mo5.7%5.3%
202528.0%14.3%
202442.8%11.5%
202329.1%5.8%
2022-26.4%4.9%
202119.6%8.8%
202011.4%-3.1%
201913.9%-6.1%
2018-6.0%1.8%
201715.0%3.9%
20160.8%-17.7%
201511.5%37.9%
201419.7%30.3%
201331.1%2.0%
201215.3%6.4%
201110.0%6.5%
20108.4%-12.6%
200930.8%-15.6%
2008-28.8%46.0%
20079.3%13.5%
20069.8%-12.8%
20059.1%-1.1%
200414.2%-2.0%
200333.3%-1.6%
2002-22.6%-3.3%
2001-14.2%7.6%
2000-10.5%1.8%
199937.6%-2.7%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FROR
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.35% (placeholder)
Inception2021-09-27 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$18.67T

Methodology

The Foundry Return on Assets Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a Return on Assets signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.